¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other specified joint disorders"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • joint
    °üÀý
  • joint aspiration
    °üÀýÈíÀÎ
  • joint capsule
    °üÀýÁÖ¸Ó´Ï, °üÀý³¶
  • joint cavity
    °üÀý¾È, °üÀý°­
  • joint contracture
    °üÀý±¸Ãà
  • joint cry
    ¹ã¼Ò¸®Áö¸§, ¾ß°æÁõ
  • joint dislocation
    °üÀýÅ»±¸
  • joint facet
    °üÀý¸é
  • joint receptor
    °üÀý¼ö¿ë±â
  • joint sense
    °üÀý°¨°¢
  • joint stiffness
    °üÀý°æÁ÷, °üÀý°­Á÷
  • knee joint
    ¹«¸­°üÀý, ½½°üÀý
  • midcarpal joint
    ¼Õ¸ñ»ÀÁß°£°üÀý, Áß¼ö°üÀý
  • mixed joint
    ¹µÃà°üÀý, ´ÙÃà°üÀý
  • multiaxial joint
    ¹µÃà°üÀý, ´ÙÃà°üÀý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fibrous joint
    ¼¶À¯°üÀý
  • flail joint
    µ¿¿ä°üÀý
  • hinge joint
    °æÃ¸°üÀý
  • hip joint
    ¾ûµ¢°üÀý, °í°üÀý
  • intercarpal joint
    ¼Õ¸ñ»À»çÀ̰üÀý
  • irritable joint
    °ú¹Î°üÀý
  • joint
    °üÀý
  • joint receptor
    °üÀý¼ö¿ë±â
  • joint sense
    °üÀý°¨°¢
  • joint stiffness
    °üÀý°æÁ÷, °üÀý°­Á÷
  • knee joint
    ¹«¸­°üÀý
  • metacarpophalangeal joint
    ¼ÕÇ㸮¼Õ°¡¶ô°üÀý
  • metatarsophalangeal joint
    ¹ßÇ㸮¹ß°¡¶ô°üÀý
  • midcarpal joint
    ¼Õ¸ñ»ÀÁß°£°üÀý
  • mixed joint
    È¥ÇÕ°üÀý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • glenohumeral joint
    »ó¿Ï¿Í °üÀý(ß¾èÓèÀμï½), °ß°üÀý, °ß°© °üÀý.
  • habitual luxation of temporomandibular joint
    ½À°ü¼º ¾Ç°üÀýÅ»±¸(ã§Î±àõäÉμï½÷­Ï¿).
  • hinge joint
    °æÃ¸°üÀý
  • hinge joint ; ginglymus
    °æÃ¸°üÀý.
  • hip joint
    ´ëÅð °üÀý, °í °üÀý(ÍÆÎ¼ï½), µÐºÎ °üÀý.
  • hip joint
    ¾ûµ¢°üÀý
  • hip joint disease
    ´ëÅð °üÀý<°í°üÀý>º´, °í°üÀý Áúȯ(ÍÆÎ¼ï½òðü´).
  • humero-ulnar joint
    À§ÆÈÀÚ°üÀý
  • humeroradial joint
    À§ÆÈ³ë°üÀý
  • humeroradial joint ³ª articulatio humeroradialis
    »ó¿Ï¿ä°ñ°üÀý, ¿Ï¿ä °üÀý(èÓèúμï½).
  • humeroradial joint ³ª articulatio humeroradialis
    »ó¿Ï ¿ä°ñ °üÀý(ß¾èÓèúÍéμï½), »ó¿Ï ¿ä °üÀý(ß¾èÓèúμï½),¿Ï¿ä °üÀý(èÓèúμï½).
  • hysteric joint
    È÷½ºÅ׸®¼º °üÀý.
  • immovable joint ³ª junctura fibrosa
    ºÎµ¿ °üÀý(ÝÕÔÑμï½).
  • incudomalleolar joint
    ħÃß°ñ°üÀý.
  • incudostapedial joint
    ħµî°ñ°üÀý.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myeloproliferative disorders
    °ñ¼öÁõ½Ä¼ºÁúȯ
  • neuroleptic-induced disorders
  • nutritional disorders
    ¿µ¾çÀÌ»ó<Àå¾Ö>.
  • olfactory disorders
    Èİ¢Àå¾Ö
  • organic voice disorders
    ±âÁú(Àû) À½¼ºÀå¾Ö
  • platelet function disorders
    Ç÷¼ÒÆÇ±â´ÉÀÌ»óÁúȯ
  • postpartum disorders
    »êÈÄ Àå¾Ö(º´)
  • psychogenic voice disorders
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
  • sensation disorders
    Áö°¢<°¨°¢>Àå¾Ö .
  • sex limited disorders
    ÇѼºÀå¾Ö(ùÚàõî¡äô)
  • sex linked disorders
    ¹Ý¼ºÀå¾Ö(Úáàõî¡äô)
  • sexual and gender identity disorders
    ¼º ¹× Á¤½Å¼ºÀû ÁÖü¼ºÀå¾Ö(º´)
  • sleep-related disorders
    ¼ö¸é°ü·ÃÀå¾Ö(º´)
  • social stress, mood disorders and
    »çȸÀû ½ºÆ®·¹½º
  • somatic disorders
    ½ÅüÀå¾Ö(ãóô÷î¡äô).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Ellipsoidal [condylar] joint
    Ÿ¿ø°üÀý
    [¿¾ ¿ë¾î] Ÿ¿ø°üÀý
  • Temporomandibular joint
    ÅΰüÀý
    [¿¾ ¿ë¾î] ¾Ç°üÀý
  • Elbow joint
    ÆÈ²ß°üÀý
    [¿¾ ¿ë¾î] ÁÖ°üÀý
  • Plane joint
    Æò¸é°üÀý
    [¿¾ ¿ë¾î] Æò¸é°üÀý
  • Lumbosacral joint
    Ç㸮¾ûÄ¡°üÀý
    [¿¾ ¿ë¾î] ¿äõ°üÀý
  • Hinge joint
    °æÃ¸°üÀý
    [¿¾ ¿ë¾î] Á¢¹ø°üÀý
  • Simple joint
    ´Ü¼ø°üÀý
    [¿¾ ¿ë¾î] ´Ü°üÀý
  • Compound joint
    º¹ÇÕ°üÀý
    [¿¾ ¿ë¾î] º¹°üÀý
  • Cuneocuboid joint
    ½û±âÀÔ¹æ°üÀý
    [¿¾ ¿ë¾î] ¼³ÀÔ¹æ°üÀý
  • Shoulder joint
    ¾î±ú°üÀý
    [¿¾ ¿ë¾î] °ß°üÀý
  • Hip joint
    ¾ûµ¢°üÀý
    [¿¾ ¿ë¾î] °í°üÀý
  • Pivot joint
    Áß¼è°üÀý
    [¿¾ ¿ë¾î] Â÷Ãà°üÀý
  • Pisiform joint
    Äá¾Ë»À°üÀý
    [¿¾ ¿ë¾î] µÎ»ó°ñ°üÀý
  • Network of elbow joint
    ÆÈ²ß°üÀýµ¿¸Æ±×¹°
    [¿¾ ¿ë¾î] ÁÖ°üÀýµ¿¸Æ¸Á
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • subaxial joint
    ÃàÇϰüÀý
  • synarthrodial joint
    °üÀýÀ¯ÇÕ¼º°üÀý, ºÎµ¿°üÀý
  • synovial joint
    À±È°°üÀý, Ȱ¸·¿¬°á
  • uniaxial joint
    ÀÏÃ༺¤Ä °üÀý
  • unstable joint
    ºÒ¾ÈÁ¤°üÀý
  • wrist joint
    ¼Õ¸ñ°üÀý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MTP joint Meta-Tarso-Phalangeal joint
PIP joint Proximal Inter-Phalangeal joint
SC joint Sterno-Clavicular joint
SI joint Sacro-Iliac joint
TM joint Temporo-Mandibular joint
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AOD and other drug
OND other neurologic disease
AJCC American Joint Commission in Cancer
AJC American Joint Committee
AJCC American Joint Committee on Cancer
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dry joint
    °Ç¼º °üÀý
  • early closing clicking joint noise
    Æó±¸ ÃʱâÀÇ ´Ü¼ø °üÀýÀâÀ½
    ÇÏ¾Ç °úµÎÀÇ ÈĹæ ȰÁÖ ¿îµ¿ Ãʱ⿡ ¹ß»ýÇÏ´Â °üÀýÀ½.
  • early opening clicking joint noise
    °³±¸ ÃʱâÀÇ ´Ü¼ø °üÀýÀâÀ½
    ÇÏ¾Ç °úµÎÀÇ Àü¹æ ȰÁֿ Ãʱ⿡ ¹ß»ýÇÏ´Â °üÀýÀ½.
  • elbow joint pain
    ÆÈ±Á °üÀýÅë
  • ellipsoid joint
    Ÿ¿øÇü °üÀý
  • enarthrosis joint
    ±¸¿Í °üÀý
    µ¿ÀǾî=s
  • fibrous joint
    ¼¶À¯ °üÀý, ¼¶À¯¼º ¿¬°á, ¼¶À¯¼º °üÀý
    °üÀý ±¸¼º¹°ÀÌ ¼¶À¯ Á¶Á÷À¸·Î °áÇյǾî ÀÖ´Â °Í.
  • flail joint
    µ¿¿ä °üÀý
  • free joint articulator
    ÀÚÀ¯ ¿îµ¿ ±³ÇÕ±â
  • functional temporomandibular joint disturbance
    ±â´ÉÀû ÃøµÎÇϾǰüÀý Àå¾Ö
  • habitual luxation of temporomandibular joint
    ½À°ü¼º ¾Ç°üÀý Å»±¸
    ½À°üÀûÀ¸·Î ÅΰüÀýÀÌ ºüÁö´Â Çö»ó.
  • hinge joint
    °æÃ¸ °üÀý
    ¿À·ÎÁö µÎ ¹æÇâÀ¸·Î¸¸ ¿îµ¿ÇÏ´Â °üÀý. Ȱ¾×.°üÀýÀÇ ÇÑ Çü, ÇÑ Æò¸é ³»¿¡¼­ ¾ÕµÚ·Î â¹®ÀÇ °æÃ¸°ú °°ÀÌ ¿òÁ÷ÀÌ´Â °üÀý.
  • hip joint
    °í °üÀý, ´ëÅð °üÀý
    üÁßÀ» ¸öÅë¿¡¼­ ÇÏÁö·Î ºÎÇÏ, Àü´ÞÇÏ´Â ±¸¿Í °üÀý.
  • inferior joint space
    ÇϰüÀý °­
  • inflammatory joint disorder
    ¿°Áõ¼º °üÀý Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
ciliary motility disorders Disorders characterised by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the cilia shows that dynein arms are missing. The disorders manifest as kartagener triad (kartagener's syndrome), chronic respiratory disorders, chronic sinusitis, and/or chronic otitis.
(12 Dec 1998)
phobic disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognises the fear as excessive or unreasonable.
(12 Dec 1998)
civil disorders Deliberate and planned acts of unlawful behaviour engaged in by aggrieved segments of the population in seeking social change.
(12 Dec 1998)
phosphorus metabolism disorders Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
photosensitivity disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.
(12 Dec 1998)
mood disorders Those disorders that have a disturbance in mood as their predominant feature.
(12 Dec 1998)
combat disorders Neurotic reactions to unusual, severe, or overwhelming military stress.
(12 Dec 1998)
communication disorders Disorders characterised by the individual's inability to comprehend or share ideas or feelings because of impairment of language, speech, or hearing.
(12 Dec 1998)
motor skills disorders Marked impairments in the development of motor coordination such that the impairment interferes with activities of daily living.
(12 Dec 1998)
platelet function disorders <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(31 Dec 1997)
multifactorial or multigenic disorders Genetic disorders resulting from the combined action of alleles of more than one gene (e.g., heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single- gene disorders.
Compare single-gene disorders.
(05 Mar 2000)
consciousness disorders Organic mental disorders in which there is marked impairment of awareness.
(12 Dec 1998)
polygenic disorders Genetic disorders resulting from the combined action of alleles of more than one gene (e.g., heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single- gene disorders.
Compare single-gene disorders.
(05 Mar 2000)
myeloproliferative disorders A group of disease states which primarily involve the bone marrow and the production blood cells.
Examples include polycythaemia vera, leukaemia, myelofibrosis and primary thrombocytopenia.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • right joint
    °ÇÀüÇÑ ¼úÁý(µµ¹ÚÀåµî);°øÁ¤ÇÑ ´ë¿ì¸¦ ¹ÞÀ» ¼ö ÀÖ´Â ±³µµ¼Ò
  • rule joint
    Á¢ÀÚ
  • scarf joint
    ¾ùÅÎÀÌÀ½;Á¢ÇÕ
  • toggle joint
    Åä±Û ÀÌÀ½¼è
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á